trial

Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia

NCTId NCT00685321
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 45 (estimated)
Sponsored by Shalvata Mental Health Center
Primary completion 2013-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
45 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2008-06
Primary completion
2013-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
H1 deep TMS coil

Sponsors

Shalvata Mental Health CenterLead Sponsor

Investigators

1
Yechiel Levkovitz, MD, PhDPrincipal Investigator

Sites

2 total
Hod HaSharon, IsraelHod HaSharon, Israel

Facts & assertions

4 sourced
Enrollment
45
Phase
NA
Primary Completion Date
2013-01
Status
UNKNOWN
relationships
The graph out of here
drug
H1 deep TMS coil
drug
lead_sponsor
Shalvata Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Yechiel Levkovitz, MD, PhD
person